NING HUI – Trademark Portfolio

Entity Type: 01

NING HUI holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. The portfolio also extends into Class 8 (Hand Tools) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FOCCRED and BLOODHOL. The owner is based in Ji'an , Jiangxi.

3 / F, unit 3, building 8, Yuejin West

Ji'an , Jiangxi 331500 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BLOODHOL
BLOODHOL
Registered 2023
FOCCRED
FOCCRED
Abandoned 2020
FOCCRED
FOCCRED
Registered 2020

Trademark Classifications

NING HUI's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

Frequently Asked Questions

How many trademarks does NING HUI have?

NING HUI has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does NING HUI file in?

NING HUI files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 8 (Hand Tools). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are NING HUI's most well-known trademarks?

NING HUI's registered trademark portfolio includes well-known marks such as FOCCRED and BLOODHOL. These are among 2 currently registered trademarks in the portfolio.

What is NING HUI's trademark registration success rate?

NING HUI has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.